Results
Zydus Lifesciences Q4 FY26 Revenue Up 16% YoY
Zydus Lifesciences reported Q4 FY26 consolidated revenue of ₹75.9 billion, up 16% YoY, with an EBITDA margin of 33.7%.
Management provided FY27 guidance, expecting high-teens revenue growth and EBITDA
